BioCentury
ARTICLE | Financial News

Coferon raises $12M in series B

July 17, 2012 12:11 AM UTC

Coferon Inc. (New York, N.Y.) raised $12 million in a series B round from new investors Hatteras Venture Partners; MedImmune Ventures; and Ascent Biomedical Ventures. Coferon uses bioorthogonal linker chemistry to deliver therapeutics that self-assemble on the target after gaining entry into a cell (see BioCentury, July 16). ...